Pipeline

Genes & Mutants

CYMD's Pipeline plans include FFPE- and Plasma-based Tests for all therapeutically relevant Solid Tumor Companion Diagnostics gene mutations, the three most prominent blood borne viral illnesses, HIV-1, HBV, HCV and for the oncovirus HPV.

Oncology CDx

  • Gene
    Number of mutants detected
  • EGFR
    48 mutants
  • KRAS
    28 mutants
    NRAS
    28 mutants
    BRAF
    7 mutants
Infectious Disease

Infectious Disease

  • Infectious Agent
    Status
  • HIV-1
    In Progress
    HBV
    Planning
    HCV
    Planning
    HPV
    Planning

Interested in our product?

If you would like to learn more, or are interested in working with us, feel free to reach out.

Contact us